Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYSCN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,304
Award facts
- Contract value 100% obligated
- $21,303.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,303.64 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
Tagrisso is a prescription oncology medication used in cancer treatment, and this delivery order fulfills federal pharmaceutical supply requirements through the DLA Medical Supply Chain. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to meet competitive procurement standards across a wide spectrum of therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The non-set-aside designation indicates this award was made through open competition, consistent with the company's track record of successfully competing for federal medical supply contracts across multiple federal agencies including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FYSCN?
SPE2DB25FYSCN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FYSCN worth?
The government has obligated $21,304 on SPE2DB25FYSCN.
Is contract SPE2DB25FYSCN an order under another contract?
Yes. SPE2DB25FYSCN is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYSCN competed?
The extent of competition for SPE2DB25FYSCN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award